title: Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression.
abstract: Several studies have shown that olanzapine is effective in weight restoration and maintenance for patients with anorexia nervosa (AN). However, major depression is a very common comorbid psychiatric disorder associated with AN. Additional antidepressant therapy may be required for treating anorexic patients with major depression. The authors present a case of AN associated with major depression, who responded well to the combination treatment of olanzapine and mirtazapine. A 27-year-old Taiwanese woman was admitted because of severe weight loss, poor nutrition, amenorrhea, major depression, and starvation complications including hematological dyscrasis, electrolytes and endocrine imbalance, and sinus bradycardia. In additional to nutritional and medical treatments, the patient was given olanzapine 10 mg/day and mirtazapine 30 mg/day. She took the combined medications for six months. Meanwhile she received cognitive behavior therapy and family therapy. With these treatments, the patient's depression was in remission, her body weight was increased from 24 to 38 kg, and her body mass index was increased from 9.8 to 15.5. Our case suggests that the combined treatment of olanzapine and mirtazapine can be used in the treatment of AN associated with major depression.
authors.affiliation: Department of Psychiatry, Tri-Service General Hospital, Taiwan.
authors.forename: Tzong-Shi
authors.initials: TS
authors.lastname: Wang
authors.forename: Yuan-Hwa
authors.initials: YH
authors.lastname: Chou
authors.forename: I-Shin
authors.initials: IS
authors.lastname: Shiah
mesh_terms: D000328:Adult; D000856:Anorexia Nervosa / Q000150:complications / Q000188:drug therapy*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D000932:Antiemetics / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008803:Mianserin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000078785:Mirtazapine; D000077152:Olanzapine
chemical_list: D000929:Antidepressive Agents, Tricyclic; D000932:Antiemetics; D001569:Benzodiazepines; D008803:Mianserin; D000078785:Mirtazapine; D000077152:Olanzapine